Taurolidine-D6

CAS : 19388-87-5

Ref. TR-T009052

Informations sur le produit

• Nom: Taurolidine-D6
• Synonymes: 4,4'-Methylenebis[tetrahydro-2H-1,2,4-thiadiazine 1,1,1',1'-Tetraoxide-D6, ‡4,4'-Methylenebis(perhydro-1,2,4-thiadiazin 1,1-dioxide)-D6, Taurolin-D6, Tauroline-D6, 2H-1,2,4-Thiadiazine, 4,4′-methylenebis[tetrahydro-, 1,1,1′,1′-tetraoxide, 4,4'-Methanediylbis(1,2,4-Thiadiazinane) 1,1,1',1'-Tetraoxide, 4,4'-Methylenebis(1,2,4-thiadiazinane) 1,1,1',1'-tetraoxide, 4,4'-Methylenebis(perhydro-1,2,4-thiadiazine 1,1-dioxide), 4,4'-Methylenebis(tetrahydro-1,2,4-thiadiazine) 1,1,1',1'-tetraoxide, 4,4′-Methylenebis(perhydro-1,2,4-thiadiazin 1,1-dioxide), Bis(1,1-dioxoperhydro-1,2,4-thiadiazin-4-yl)methane, T 7329, Taurolin, Tauroline

Description

Stability Unstable in Aqueous Solution
Applications Taurolidine-D6 is a labelled analogue of Taurolidine (T009050). Taurolidine is a derivative of the amino acid Taurine (T007850). Taurolidine exhibits antiendotoxin and antimicrobial activity, and has also been shown to exhibit antitumour activity in vitro and in vivo. Taurolidine is used for the treatment of sepsis and is utilized in hospitals to prevent catheter-related bloodstream infections.
References Jurewitsch, B., et al.: J. Parent. Enter. Nut., 22, 242 (1998); McCourt, M., et al.: Ann. Surg. Oncol., 7, 685 (2000); Willatts, S., et al.: Crit. Care Med., 23, 1033 (1995)

• Marque: TRC

Propriétés chimiques

• Masse moléculaire: 290.393
• Formule: C₇D₆H₁₀N₄O₄S₂
• Couleur/Forme: Neat
• InChI: InChI=1S/C7H16N4O4S2/c12-16(13)3-1-10(5-8-16)7-11-2-4-17(14,15)9-6-11/h8-9H,1-7H2/i5D2,6D2,7D2
• Code InChI: InChIKey=AJKIRUJIDFJUKJ-IPSWUHLQSA-N
• SMILES: [2H]C1([2H])NS(=O)(=O)CCN1C([2H])([2H])N1CCS(=O)(=O)NC1([2H])[2H]